|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 73.51 INR | +5.00% |
|
+9.52% | -8.27% |
| Market Cap | 1.09B 11.57M 10.11M 9.35M 8.73M 16.38M 16.5M 111M 43.23M 537M 43.43M 42.49M 1.87B | P/E 2024 |
-12.2x | P/E 2025 | -28.6x |
|---|---|---|---|---|---|
| Enterprise Value | 1.17B 12.37M 10.8M 9.99M 9.33M 17.51M 17.64M 119M 46.21M 575M 46.43M 45.42M 2B | EV / Sales 2024 |
3.16x | EV / Sales 2025 | 3.93x |
| Free-Float |
43.99% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +5.00% | ||
| 1 week | +9.52% | ||
| Current month | +12.59% | ||
| 1 month | +30.31% | ||
| 3 months | +59.70% | ||
| 6 months | -20.69% | ||
| Current year | -8.27% |
| 1 week | 66.1 |  | 73.51 |
| 1 month | 54.54 | | 73.51 |
| Current year | 36.3 | | 82.44 |
| 1 year | 36.3 | | 164.02 |
| 3 years | 36.3 | | 198.86 |
| 5 years | 36.3 | | 198.86 |
| 10 years | 13.85 | | 198.86 |
| Manager | Title | Age | Since |
|---|---|---|---|
Prashant Rathi
CEO | Chief Executive Officer | - | 2026-05-31 |
Atul Ranchal
PSD | President | 57 | 2023-08-22 |
D. S. Maity
CTO | Chief Tech/Sci/R&D Officer | 62 | 2023-08-01 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 62 | 2010-09-09 | |
Lalit Mahajan
BRD | Director/Board Member | 60 | 2011-09-12 |
| Director/Board Member | 53 | 2022-11-22 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +5.00% | +9.52% | -46.86% | +0.35% | 21.82M | |
| +1.67% | +5.16% | +13.91% | +91.00% | 47.3B | |
| +1.27% | +3.76% | +54.90% | +96.81% | 34.61B | |
| +2.97% | +6.28% | -2.64% | +47.51% | 12.1B | |
| +3.31% | +3.78% | +17.58% | +100.95% | 11.56B | |
| -0.95% | -0.57% | +37.43% | +124.36% | 9.02B | |
| +1.11% | -2.15% | +14.48% | +41.36% | 7.02B | |
| +0.33% | +2.00% | +30.57% | +247.52% | 6.55B | |
| -0.21% | +3.54% | +51.88% | -14.26% | 6.83B | |
| +1.32% | -1.72% | -34.40% | -0.52% | 5.07B | |
| Average | +1.58% | +1.50% | +13.69% | +73.51% | 14.01B | |
| Weighted average by Cap. | +1.45% | +2.32% | +25.33% | +88.02% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 795M 8.41M 7.35M 6.8M 6.35M 11.91M 12M 80.79M 31.43M 391M 31.58M 30.89M 1.36B | 826M 8.74M 7.63M 7.06M 6.59M 12.37M 12.46M 83.91M 32.65M 406M 32.8M 32.09M 1.41B |
| Net income | -196M -2.07M -1.81M -1.68M -1.56M -2.94M -2.96M -19.91M -7.75M -96.33M -7.78M -7.62M -335M | -99.67M -1.05M -922K -852K -796K -1.49M -1.5M -10.13M -3.94M -49M -3.96M -3.87M -170M |
| Net Debt | 55.16M 584K 510K 472K 440K 827K 833K 5.61M 2.18M 27.12M 2.19M 2.14M 94.22M | 75.39M 798K 697K 645K 602K 1.13M 1.14M 7.66M 2.98M 37.07M 3M 2.93M 129M |
Employees
323
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-06-23 | 73.51 ₹ | +5.00% | 51,001 |
| 26-06-22 | 70.01 ₹ | +4.99% | 20,569 |
| 26-06-19 | 66.68 ₹ | -1.94% | 12,640 |
| 26-06-18 | 68.00 ₹ | +1.54% | 29,948 |
| 26-06-17 | 66.97 ₹ | -0.22% | 7,156 |
- Stock Market
- Stocks
- BROOKS Stock
Select your edition
All financial news and data tailored to specific country editions
